Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002460:Cell Line; D003630:Daunorubicin / Q000378:metabolism / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D004351:Drug Resistance; D005944:Glucosamine / Q000031:analogs & derivatives*; D006023:Glycoproteins / Q000096:biosynthesis; D007941:Leukemia P388 / Q000188:drug therapy* / Q000378:metabolism; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D009279:Naphthacenes / Q000494:pharmacology; D014415:Tunicamycin / Q000494:pharmacology* / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D006023:Glycoproteins; D009279:Naphthacenes; D014415:Tunicamycin; D004317:Doxorubicin; D005944:Glucosamine; D003630:Daunorubicin